<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1995-11-01" modified="2020-10-07" version="225">
<accession>P42771</accession>
<accession>A5X2G7</accession>
<accession>D3DRK1</accession>
<accession>G3XAG3</accession>
<accession>O95440</accession>
<accession>Q15191</accession>
<accession>Q5VVJ5</accession>
<accession>Q96B52</accession>
<accession>Q9NP05</accession>
<name>CDN2A_HUMAN</name>
<protein>
<recommendedName>
<fullName evidence="32">Cyclin-dependent kinase inhibitor 2A</fullName>
</recommendedName>
<alternativeName>
<fullName>Cyclin-dependent kinase 4 inhibitor A</fullName>
<shortName>CDK4I</shortName>
</alternativeName>
<alternativeName>
<fullName>Multiple tumor suppressor 1</fullName>
<shortName>MTS-1</shortName>
</alternativeName>
<alternativeName>
<fullName>p16-INK4a</fullName>
<shortName>p16-INK4</shortName>
<shortName>p16INK4A</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="32">CDKN2A</name>
<name type="synonym">CDKN2</name>
<name type="synonym">MTS1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Nature" volume="366" first="704" last="707">
<title>A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.</title>
<authorList>
<person name="Serrano M."/>
<person name="Hannon G.J."/>
<person name="Beach D."/>
</authorList>
<dbReference type="PubMed" id="8259215"/>
<dbReference type="DOI" id="10.1038/366704a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Oncogene" volume="18" first="3810" last="3820">
<title>Tissue-specific alternative splicing in the human INK4a/ARF cell cycle regulatory locus.</title>
<authorList>
<person name="Robertson K.D."/>
<person name="Jones P.A."/>
</authorList>
<dbReference type="PubMed" id="10445844"/>
<dbReference type="DOI" id="10.1038/sj.onc.1202737"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="46289" last="46297">
<title>Prevalent involvement of illegitimate V(D)J recombination in chromosome 9p21 deletions in lymphoid leukemia.</title>
<authorList>
<person name="Kitagawa Y."/>
<person name="Inoue K."/>
<person name="Sasaki S."/>
<person name="Hayashi Y."/>
<person name="Matsuo Y."/>
<person name="Lieber M.R."/>
<person name="Mizoguchi H."/>
<person name="Yokota J."/>
<person name="Kohno T."/>
</authorList>
<dbReference type="PubMed" id="12228235"/>
<dbReference type="DOI" id="10.1074/jbc.m208353200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="7017" last="7027">
<title>Human p16gamma, a novel transcriptional variant of p16(INK4A), coexpresses with p16(INK4A) in cancer cells and inhibits cell-cycle progression.</title>
<authorList>
<person name="Lin Y.C."/>
<person name="Diccianni M.B."/>
<person name="Kim Y."/>
<person name="Lin H.H."/>
<person name="Lee C.H."/>
<person name="Lin R.J."/>
<person name="Joo S.H."/>
<person name="Li J."/>
<person name="Chuang T.J."/>
<person name="Yang A.S."/>
<person name="Kuo H.H."/>
<person name="Tsai M.D."/>
<person name="Yu A.L."/>
</authorList>
<dbReference type="PubMed" id="17486064"/>
<dbReference type="DOI" id="10.1038/sj.onc.1210507"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="5">
<citation type="submission" date="2002-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="1996" name="Mol. Cell. Biol." volume="16" first="859" last="867">
<title>Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence.</title>
<authorList>
<person name="Hara E."/>
<person name="Smith R."/>
<person name="Parry D."/>
<person name="Tahara H."/>
<person name="Stone S."/>
<person name="Peters G."/>
</authorList>
<dbReference type="PubMed" id="8622687"/>
<dbReference type="DOI" id="10.1128/mcb.16.3.859"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-20</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1994" name="Nature" volume="368" first="753" last="756">
<title>Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers.</title>
<authorList>
<person name="Nobori T."/>
<person name="Miura K."/>
<person name="Wu D.J."/>
<person name="Lois A."/>
<person name="Takabayashi K."/>
<person name="Carson D.A."/>
</authorList>
<dbReference type="PubMed" id="8152487"/>
<dbReference type="DOI" id="10.1038/368753a0"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 51-156</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1994" name="Science" volume="264" first="436" last="440">
<title>A cell cycle regulator potentially involved in genesis of many tumor types.</title>
<authorList>
<person name="Kamb A."/>
<person name="Gruis N.A."/>
<person name="Weaver-Feldhaus J."/>
<person name="Liu Q."/>
<person name="Harshman K."/>
<person name="Tavtigian S.V."/>
<person name="Stockert E."/>
<person name="Day R.S. III"/>
<person name="Johnson B.E."/>
<person name="Skolnick M.H."/>
</authorList>
<dbReference type="PubMed" id="8153634"/>
<dbReference type="DOI" id="10.1126/science.8153634"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 51-152</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1994" name="Proc. Natl. Acad. Sci. U.S.A." volume="91" first="11045" last="11049">
<title>Mutations and altered expression of p16INK4 in human cancer.</title>
<authorList>
<person name="Okamoto A."/>
<person name="Demetrick D.J."/>
<person name="Spillare E.A."/>
<person name="Hagiwara K."/>
<person name="Hussain S.P."/>
<person name="Bennett W.P."/>
<person name="Forrester K."/>
<person name="Gerwin B."/>
<person name="Serrano M."/>
<person name="Beach D.H."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="7972006"/>
<dbReference type="DOI" id="10.1073/pnas.91.23.11045"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="6619" last="6622">
<title>Phosphorylation of p16INK4A correlates with Cdk4 association.</title>
<authorList>
<person name="Gump J."/>
<person name="Stokoe D."/>
<person name="McCormick F."/>
</authorList>
<dbReference type="PubMed" id="12529334"/>
<dbReference type="DOI" id="10.1074/jbc.c200622200"/>
</citation>
<scope>PHOSPHORYLATION AT SER-7; SER-8; SER-140 AND SER-152</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2006" name="Mol. Cell. Biol." volume="26" first="5070" last="5085">
<title>Regulated activating Thr172 phosphorylation of cyclin-dependent kinase 4(CDK4): its relationship with cyclins and CDK 'inhibitors'.</title>
<authorList>
<person name="Bockstaele L."/>
<person name="Kooken H."/>
<person name="Libert F."/>
<person name="Paternot S."/>
<person name="Dumont J.E."/>
<person name="de Launoit Y."/>
<person name="Roger P.P."/>
<person name="Coulonval K."/>
</authorList>
<dbReference type="PubMed" id="16782892"/>
<dbReference type="DOI" id="10.1128/mcb.02006-05"/>
</citation>
<scope>INTERACTION WITH CDK4</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2007" name="Biochem. Biophys. Res. Commun." volume="361" first="287" last="293">
<title>Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a.</title>
<authorList>
<person name="Huang X."/>
<person name="Shi Z."/>
<person name="Wang W."/>
<person name="Bai J."/>
<person name="Chen Z."/>
<person name="Xu J."/>
<person name="Zhang D."/>
<person name="Fu S."/>
</authorList>
<dbReference type="PubMed" id="17658461"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2007.06.181"/>
</citation>
<scope>INTERACTION WITH ISOC2</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1998" name="Nature" volume="395" first="237" last="243">
<title>Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.</title>
<authorList>
<person name="Russo A.A."/>
<person name="Tong L."/>
<person name="Lee J.O."/>
<person name="Jeffrey P.D."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="9751050"/>
<dbReference type="DOI" id="10.1038/26155"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF COMPLEX WITH CDK6</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1999" name="J. Mol. Biol." volume="294" first="201" last="211">
<title>Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).</title>
<authorList>
<person name="Yuan C."/>
<person name="Li J."/>
<person name="Selby T.L."/>
<person name="Byeon I.-J."/>
<person name="Tsai M.-D."/>
</authorList>
<dbReference type="PubMed" id="10556039"/>
<dbReference type="DOI" id="10.1006/jmbi.1999.3231"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Protein Sci." volume="9" first="1120" last="1128">
<title>Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data.</title>
<authorList>
<person name="Yuan C."/>
<person name="Selby T.L."/>
<person name="Li J."/>
<person name="Byeon I.J."/>
<person name="Tsai M.D."/>
</authorList>
<dbReference type="PubMed" id="10892805"/>
<dbReference type="DOI" id="10.1110/ps.9.6.1120"/>
</citation>
<scope>STRUCTURE BY NMR</scope>
</reference>
<reference key="21">
<citation type="journal article" date="1996" name="Cancer Surv." volume="26" first="115" last="132">
<title>CDKN2 mutations in melanoma.</title>
<authorList>
<person name="Dracopoli N.C."/>
<person name="Fountain J.W."/>
</authorList>
<dbReference type="PubMed" id="8783570"/>
</citation>
<scope>REVIEW ON MELANOMA VARIANTS</scope>
</reference>
<reference key="22">
<citation type="journal article" date="1996" name="Hum. Mutat." volume="7" first="294" last="303">
<title>CDKN2A (p16INK4A) somatic and germline mutations.</title>
<authorList>
<person name="Smith-Soerensen B."/>
<person name="Hovig E."/>
</authorList>
<dbReference type="PubMed" id="8723678"/>
<dbReference type="DOI" id="10.1002/(sici)1098-1004(1996)7:4&lt;294::aid-humu2&gt;3.0.co;2-9"/>
</citation>
<scope>REVIEW ON VARIANTS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="1994" name="Biochem. Biophys. Res. Commun." volume="202" first="1426" last="1430">
<title>Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4l (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas.</title>
<authorList>
<person name="Hayashi N."/>
<person name="Sugimoto Y."/>
<person name="Tsuchiya E."/>
<person name="Ogawa M."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="8060323"/>
<dbReference type="DOI" id="10.1006/bbrc.1994.2090"/>
</citation>
<scope>VARIANTS NON-SMALL CELL LUNG CARCINOMA TYR-66; HIS-84; ALA-93; ALA-95; GLN-99; LEU-114; ALA-120; LYS-120; PRO-132; VAL-134; TYR-142 AND VAL-150</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1994" name="Nat. Genet." volume="8" first="15" last="21">
<title>Germline p16 mutations in familial melanoma.</title>
<authorList>
<person name="Hussussian C.J."/>
<person name="Struewing J.P."/>
<person name="Goldstein A.M."/>
<person name="Higgins P.A.T."/>
<person name="Ally D.S."/>
<person name="Sheahan M.D."/>
<person name="Clark W.H. Jr."/>
<person name="Tucker M.A."/>
<person name="Dracopoli N.C."/>
</authorList>
<dbReference type="PubMed" id="7987387"/>
<dbReference type="DOI" id="10.1038/ng0994-15"/>
</citation>
<scope>VARIANTS CMM2 PRO-87; TRP-101 AND ASP-126</scope>
<scope>VARIANTS THR-49; SER-71 AND THR-148</scope>
</reference>
<reference key="25">
<citation type="journal article" date="1994" name="Oncogene" volume="9" first="3737" last="3741">
<title>The MTS1 gene is frequently mutated in primary human esophageal tumors.</title>
<authorList>
<person name="Zhou X."/>
<person name="Tarmin L."/>
<person name="Yin J."/>
<person name="Jiang H.-Y."/>
<person name="Suzuki H."/>
<person name="Rhyu M.-G."/>
<person name="Abraham J.M."/>
<person name="Meltzer S.J."/>
</authorList>
<dbReference type="PubMed" id="7970734"/>
</citation>
<scope>VARIANTS SQUAMOUS CELL CARCINOMA SER-127 AND CYS-144</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1995" name="Cancer Res." volume="55" first="1448" last="1451">
<title>Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.</title>
<authorList>
<person name="Okamoto A."/>
<person name="Hussain S.P."/>
<person name="Hagiwara K."/>
<person name="Spillare E.A."/>
<person name="Rusin M.R."/>
<person name="Demetrick D.J."/>
<person name="Serrano M."/>
<person name="Hannon G.J."/>
<person name="Shiseki M."/>
<person name="Zariwala M."/>
<person name="Xiong Y."/>
<person name="Beach D.H."/>
<person name="Yokota J."/>
<person name="Harris C.C."/>
</authorList>
<dbReference type="PubMed" id="7882351"/>
</citation>
<scope>VARIANTS</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1995" name="Hum. Mol. Genet." volume="4" first="1845" last="1852">
<title>Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds.</title>
<authorList>
<person name="Walker G.J."/>
<person name="Hussussian C.J."/>
<person name="Flores J.F."/>
<person name="Glendening J.M."/>
<person name="Haluska F.G."/>
<person name="Dracopoli N.C."/>
<person name="Hayward N.K."/>
<person name="Fountain J.W."/>
</authorList>
<dbReference type="PubMed" id="8595405"/>
<dbReference type="DOI" id="10.1093/hmg/4.10.1845"/>
</citation>
<scope>VARIANTS CMM2 PRO-32; ALA-35; GLU-35; ARG-50 AND ILE-53</scope>
<scope>VARIANT THR-148</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1995" name="Nat. Genet." volume="10" first="114" last="116">
<title>Mutations associated with familial melanoma impair p16INK4 function.</title>
<authorList>
<person name="Ranade K."/>
<person name="Hussussian C.J."/>
<person name="Sikorski R.S."/>
<person name="Varmus H.E."/>
<person name="Goldstein A.M."/>
<person name="Tucker M.A."/>
<person name="Serrano M."/>
<person name="Hannon G.J."/>
<person name="Beach D."/>
<person name="Dracopoli N.C."/>
</authorList>
<dbReference type="PubMed" id="7647780"/>
<dbReference type="DOI" id="10.1038/ng0595-114"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS THR-49; SER-71; LEU-81; PRO-87; TRP-101; ASP-126 AND THR-148</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1996" name="Cancer Res." volume="56" first="2497" last="2500">
<title>Novel germline p16 mutation in familial malignant melanoma in southern Sweden.</title>
<authorList>
<person name="Borg A."/>
<person name="Johannsson U."/>
<person name="Johannsson O."/>
<person name="Haakansson S."/>
<person name="Westerdahl J."/>
<person name="Maasbaeck A."/>
<person name="Olsson H."/>
<person name="Ingvar C."/>
</authorList>
<dbReference type="PubMed" id="8653684"/>
</citation>
<scope>VARIANT CMM2 ARG-112 INS</scope>
<scope>VARIANT THR-148</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1996" name="Proc. Natl. Acad. Sci. U.S.A." volume="93" first="8541" last="8545">
<title>Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.</title>
<authorList>
<person name="Fitzgerald M.G."/>
<person name="Harkin D.P."/>
<person name="Silva-Arrieta S."/>
<person name="Macdonald D.J."/>
<person name="Lucchina L.C."/>
<person name="Unsal H."/>
<person name="O'Neill E."/>
<person name="Koh J."/>
<person name="Finkelstein D.M."/>
<person name="Isselbacher K.J."/>
<person name="Sober A.J."/>
<person name="Haber D.A."/>
</authorList>
<dbReference type="PubMed" id="8710906"/>
<dbReference type="DOI" id="10.1073/pnas.93.16.8541"/>
</citation>
<scope>VARIANTS CMM2 ILE-53 AND CYS-107</scope>
<scope>VARIANTS VAL-68; THR-85 AND THR-148</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1997" name="Hum. Mol. Genet." volume="6" first="2061" last="2067">
<title>Germline mutations of the CDKN2 gene in UK melanoma families.</title>
<authorList>
<person name="Harland M."/>
<person name="Meloni R."/>
<person name="Gruis N."/>
<person name="Pinney E."/>
<person name="Brookes S."/>
<person name="Spurr N.K."/>
<person name="Frischauf A.-M."/>
<person name="Bataille V."/>
<person name="Peters G."/>
<person name="Cuzick J."/>
<person name="Selby P."/>
<person name="Bishop D.T."/>
<person name="Bishop J.N."/>
</authorList>
<dbReference type="PubMed" id="9328469"/>
<dbReference type="DOI" id="10.1093/hmg/6.12.2061"/>
</citation>
<scope>VARIANTS CMM2 PRO-24; ILE-53 AND THR-118</scope>
<scope>VARIANT THR-148</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="209" last="216">
<title>Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France.</title>
<authorList>
<person name="Soufir N."/>
<person name="Avril M.-F."/>
<person name="Chompret A."/>
<person name="Demenais F."/>
<person name="Bombled J."/>
<person name="Spatz A."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Benard J."/>
<person name="Bressac-De Paillerets B."/>
</authorList>
<dbReference type="PubMed" id="9425228"/>
<dbReference type="DOI" id="10.1093/hmg/7.2.209"/>
</citation>
<scope>VARIANTS CMM2</scope>
</reference>
<reference key="33">
<citation type="journal article" date="1998" name="Hum. Mol. Genet." volume="7" first="941" last="941">
<authorList>
<person name="Soufir N."/>
<person name="Avril M.-F."/>
<person name="Chompret A."/>
<person name="Demenais F."/>
<person name="Bombled J."/>
<person name="Spatz A."/>
<person name="Stoppa-Lyonnet D."/>
<person name="Benard J."/>
<person name="Bressac-De Paillerets B."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:9425228</scope>
</reference>
<reference key="34">
<citation type="journal article" date="1998" name="Hum. Mutat." volume="12" first="212" last="212">
<title>Five novel somatic CDKN2/p16 mutations identified in melanoma, glioma and carcinoma of the pancreas.</title>
<authorList>
<person name="Gretarsdottir S."/>
<person name="Olafsdottir G.H."/>
<person name="Borg A."/>
</authorList>
<dbReference type="PubMed" id="10651484"/>
</citation>
<scope>VARIANTS CMM2 LEU-48; ASP-89 AND MET-117</scope>
<scope>VARIANT PANCREAS CARCINOMA VAL-57</scope>
<scope>VARIANT THR-148</scope>
</reference>
<reference key="35">
<citation type="journal article" date="1999" name="Cancer Genet. Cytogenet." volume="113" first="145" last="151">
<title>Hereditary TP53 codon 292 and somatic P16INK4A codon 94 mutations in a Li-Fraumeni syndrome family.</title>
<authorList>
<person name="Gueran S."/>
<person name="Tunca Y."/>
<person name="Imirzalioglu N."/>
</authorList>
<dbReference type="PubMed" id="10484981"/>
<dbReference type="DOI" id="10.1016/s0165-4608(98)00276-3"/>
</citation>
<scope>VARIANT GLU-102</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2001" name="Br. J. Cancer" volume="85" first="527" last="530">
<title>A common founder for the V126D CDKN2A mutation in seven North American melanoma-prone families.</title>
<authorList>
<person name="Goldstein A.M."/>
<person name="Liu L."/>
<person name="Shennan M.G."/>
<person name="Hogg D."/>
<person name="Tucker M.A."/>
<person name="Struewing J.P."/>
</authorList>
<dbReference type="PubMed" id="11506491"/>
<dbReference type="DOI" id="10.1054/bjoc.2001.1944"/>
</citation>
<scope>VARIANT CMM2 ASP-126</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2001" name="Hum. Mol. Genet." volume="10" first="55" last="62">
<title>A germline deletion of p14(ARF) but not CDKN2A in a melanoma-neural system tumour syndrome family.</title>
<authorList>
<person name="Randerson-Moor J.A."/>
<person name="Harland M."/>
<person name="Williams S."/>
<person name="Cuthbert-Heavens D."/>
<person name="Sheridan E."/>
<person name="Aveyard J."/>
<person name="Sibley K."/>
<person name="Whitaker L."/>
<person name="Knowles M."/>
<person name="Bishop J.N."/>
<person name="Bishop D.T."/>
</authorList>
<dbReference type="PubMed" id="11136714"/>
<dbReference type="DOI" id="10.1093/hmg/10.1.55"/>
</citation>
<scope>INVOLVEMENT IN MASTS</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2002" name="Hum. Mol. Genet." volume="11" first="1273" last="1279">
<title>Germline mutation of ARF in a melanoma kindred.</title>
<authorList>
<person name="Hewitt C."/>
<person name="Lee Wu C."/>
<person name="Evans G."/>
<person name="Howell A."/>
<person name="Elles R.G."/>
<person name="Jordan R."/>
<person name="Sloan P."/>
<person name="Read A.P."/>
<person name="Thakker N."/>
</authorList>
<dbReference type="PubMed" id="12019208"/>
<dbReference type="DOI" id="10.1093/hmg/11.11.1273"/>
</citation>
<scope>VARIANT CMM2 ARG-122</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1999" name="J. Med. Genet." volume="36" first="490" last="493">
<title>CDKN2A mutations in Spanish cutaneous malignant melanoma families and patients with multiple melanomas and other neoplasia.</title>
<authorList>
<person name="Ruiz A."/>
<person name="Puig S."/>
<person name="Malvehy J."/>
<person name="Lazaro C."/>
<person name="Lynch M."/>
<person name="Gimenez-Arnau A.M."/>
<person name="Puig L."/>
<person name="Sanchez-Conejo J."/>
<person name="Estivill X."/>
<person name="Castel T."/>
</authorList>
<dbReference type="PubMed" id="10874641"/>
</citation>
<scope>VARIANTS CMM2 GLY-59; TYR-84; TRP-87 AND TRP-101</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2003" name="Invest. Ophthalmol. Vis. Sci." volume="44" first="458" last="462">
<title>Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.</title>
<authorList>
<person name="Hearle N."/>
<person name="Damato B.E."/>
<person name="Humphreys J."/>
<person name="Wixey J."/>
<person name="Green H."/>
<person name="Stone J."/>
<person name="Easton D.F."/>
<person name="Houlston R.S."/>
</authorList>
<dbReference type="PubMed" id="12556369"/>
<dbReference type="DOI" id="10.1167/iovs.02-0026"/>
</citation>
<scope>POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO UVEAL MELANOMA</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2003" name="Melanoma Res." volume="13" first="567" last="570">
<title>A novel L94Q mutation in the CDKN2A gene in a melanoma kindred.</title>
<authorList>
<person name="Avbelj M."/>
<person name="Hocevar M."/>
<person name="Trebusak-Podkrajsek K."/>
<person name="Krzisnik C."/>
<person name="Battelino T."/>
</authorList>
<dbReference type="PubMed" id="14646619"/>
<dbReference type="DOI" id="10.1097/01.cmr.0000056289.15046.c0"/>
</citation>
<scope>VARIANT CMM2 GLN-94</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2009" name="Hum. Mutat." volume="30" first="564" last="574">
<title>Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients.</title>
<authorList>
<person name="Kannengiesser C."/>
<person name="Brookes S."/>
<person name="del Arroyo A.G."/>
<person name="Pham D."/>
<person name="Bombled J."/>
<person name="Barrois M."/>
<person name="Mauffret O."/>
<person name="Avril M.F."/>
<person name="Chompret A."/>
<person name="Lenoir G.M."/>
<person name="Sarasin A."/>
<person name="Peters G."/>
<person name="Bressac-de Paillerets B."/>
</authorList>
<dbReference type="PubMed" id="19260062"/>
<dbReference type="DOI" id="10.1002/humu.20845"/>
</citation>
<scope>VARIANTS CMM2 THR-ALA-19 INS; VAL-35; ARG-67; 67-GLY--ASN-71 DEL; TYR-74; PRO-77; PRO-80; THR-81 AND ARG-97</scope>
<scope>VARIANTS GLN-24; GLY-69 AND SER-114</scope>
<scope>CHARACTERIZATION OF VARIANTS</scope>
</reference>
<comment type="function">
<text evidence="16 21">Acts as a negative regulator of the proliferation of normal cells by interacting strongly with CDK4 and CDK6. This inhibits their ability to interact with cyclins D and to phosphorylate the retinoblastoma protein.</text>
</comment>
<comment type="subunit">
<text evidence="16 17">Heterodimer with CDK4 or CDK6. Predominant p16 complexes contained CDK6. Interacts with CDK4 (both 'T-172'-phosphorylated and non-phosphorylated forms); the interaction inhibits cyclin D-CDK4 kinase activity. Interacts with ISCO2.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-295644">
<id>P11802</id>
<label>CDK4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-295663">
<id>Q00534</id>
<label>CDK6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>15</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-3935314">
<id>Q6UXH1</id>
<label>CRELD2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-718185">
<id>O75398</id>
<label>DEAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-351126">
<id>Q00839</id>
<label>HNRNPU</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-374900">
<id>Q14566</id>
<label>MCM6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-358311">
<id>P12004</id>
<label>PCNA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-375053">
<id>P42771</id>
</interactant>
<interactant intactId="EBI-624505">
<id>Q8NHU6</id>
<label>TDRD7</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P42771-1</id>
<name>1</name>
<name>p16INK4a</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P42771-2</id>
<name>2</name>
<sequence type="described" ref="VSP_015864"/>
</isoform>
<isoform>
<id>P42771-3</id>
<name>3</name>
<name>p12</name>
<sequence type="described" ref="VSP_015865 VSP_015866"/>
</isoform>
<isoform>
<id>Q8N726-1</id>
<name>tumor suppressor ARF</name>
<name>p14ARF</name>
<name>p19ARF</name>
<sequence type="external"/>
</isoform>
<isoform>
<id>P42771-4</id>
<name>5</name>
<name>p16gamma</name>
<sequence type="described" ref="VSP_043577"/>
</isoform>
<isoform>
<id>Q8N726-2</id>
<name>smARF</name>
<sequence type="external"/>
</isoform>
<text>Isoform 1 and isoform tumor suppressor ARF arise due to the use of two alternative first exons joined to a common exon 2 at the same acceptor site but in different reading frames, resulting in two completely different isoforms.</text>
</comment>
<comment type="tissue specificity">
<text evidence="7">Widely expressed but not detected in brain or skeletal muscle. Isoform 3 is pancreas-specific.</text>
</comment>
<comment type="PTM">
<text evidence="14">Phosphorylation seems to increase interaction with CDK4.</text>
</comment>
<comment type="disease">
<text>The association between cutaneous and uveal melanomas in some families suggests that mutations in CDKN2A may account for a proportion of uveal melanomas. However, CDKN2A mutations are rarely found in uveal melanoma patients.</text>
</comment>
<comment type="disease" evidence="9 10 12 13 15 18 22 24 25 26 27 28">
<disease id="DI-01459">
<name>Melanoma, cutaneous malignant 2</name>
<acronym>CMM2</acronym>
<description>A malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.</description>
<dbReference type="MIM" id="155601"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01558">
<name>Familial atypical multiple mole melanoma-pancreatic carcinoma syndrome</name>
<acronym>FAMMMPC</acronym>
<description>An inherited cancer predisposition syndrome characterized by an increased risk of developing malignant melanoma and/or pancreatic cancer. Mutation carriers within families may develop either or both types of cancer.</description>
<dbReference type="MIM" id="606719"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-01961">
<name>Melanoma-astrocytoma syndrome</name>
<acronym>MASTS</acronym>
<description>Characterized by a dual predisposition to melanoma and neural system tumors, commonly astrocytoma.</description>
<dbReference type="MIM" id="155755"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="31">Barely detectable in non-tumor cells.</text>
</comment>
<comment type="similarity">
<text evidence="31">Belongs to the CDKN2 cyclin-dependent kinase inhibitor family.</text>
</comment>
<comment type="caution">
<text evidence="31">The proteins described here are encoded by the gene CDKN2A, but are completely unrelated in terms of sequence and function to tumor suppressor ARF (AC Q8N726) which is encoded by the same gene.</text>
</comment>
<comment type="sequence caution" evidence="31">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAB60645" version="1"/>
</conflict>
</comment>
<comment type="online information" name="CDKN2A Database">
<link uri="https://biodesktop.uvm.edu/perl/p16"/>
<text>Database of CDKN2A germline and somatic variants</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/cdkn2a/"/>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/P16INK4a"/>
<text>P16INK4a entry</text>
</comment>
<dbReference type="EMBL" id="L27211">
<property type="protein sequence ID" value="AAA92554.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF115544">
<property type="protein sequence ID" value="AAD11437.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB060808">
<property type="protein sequence ID" value="BAB91133.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF527803">
<property type="protein sequence ID" value="AAR05391.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ318021">
<property type="protein sequence ID" value="ABC47036.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL449423">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58598.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58599.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471071">
<property type="protein sequence ID" value="EAW58603.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="X94154">
<property type="protein sequence ID" value="CAA63870.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AH007355">
<property type="protein sequence ID" value="AAD14050.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S69804">
<property type="protein sequence ID" value="AAD14048.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U12820">
<property type="protein sequence ID" value="AAB60645.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U12818">
<property type="protein sequence ID" value="AAB60645.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U12819">
<property type="protein sequence ID" value="AAB60645.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56565.1">
<molecule id="P42771-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6510.1">
<molecule id="P42771-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS87644.1">
<molecule id="P42771-2"/>
</dbReference>
<dbReference type="PIR" id="JE0141">
<property type="entry name" value="JE0141"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000068.1">
<molecule id="P42771-1"/>
<property type="nucleotide sequence ID" value="NM_000077.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001182061.1">
<molecule id="P42771-4"/>
<property type="nucleotide sequence ID" value="NM_001195132.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_478104.2">
<molecule id="P42771-3"/>
<property type="nucleotide sequence ID" value="NM_058197.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005251400.1">
<molecule id="P42771-2"/>
<property type="nucleotide sequence ID" value="XM_005251343.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011515981.1">
<property type="nucleotide sequence ID" value="XM_011517679.1"/>
</dbReference>
<dbReference type="PDB" id="1A5E">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-156"/>
</dbReference>
<dbReference type="PDB" id="1BI7">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.40"/>
<property type="chains" value="B=1-156"/>
</dbReference>
<dbReference type="PDB" id="1DC2">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-156"/>
</dbReference>
<dbReference type="PDB" id="2A5E">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-156"/>
</dbReference>
<dbReference type="PDBsum" id="1A5E"/>
<dbReference type="PDBsum" id="1BI7"/>
<dbReference type="PDBsum" id="1DC2"/>
<dbReference type="PDBsum" id="2A5E"/>
<dbReference type="BMRB" id="P42771"/>
<dbReference type="SMR" id="P42771"/>
<dbReference type="BioGRID" id="107463">
<property type="interactions" value="236"/>
</dbReference>
<dbReference type="CORUM" id="P42771"/>
<dbReference type="DIP" id="DIP-6108N"/>
<dbReference type="IntAct" id="P42771">
<property type="interactions" value="63"/>
</dbReference>
<dbReference type="MINT" id="P42771"/>
<dbReference type="STRING" id="9606.ENSP00000418915"/>
<dbReference type="iPTMnet" id="P42771"/>
<dbReference type="PhosphoSitePlus" id="P42771"/>
<dbReference type="BioMuta" id="CDKN2A"/>
<dbReference type="DMDM" id="3041660"/>
<dbReference type="CPTAC" id="CPTAC-333"/>
<dbReference type="CPTAC" id="CPTAC-334"/>
<dbReference type="EPD" id="P42771"/>
<dbReference type="jPOST" id="P42771"/>
<dbReference type="MassIVE" id="P42771"/>
<dbReference type="PaxDb" id="P42771"/>
<dbReference type="PeptideAtlas" id="P42771"/>
<dbReference type="PRIDE" id="P42771"/>
<dbReference type="ProteomicsDB" id="33740"/>
<dbReference type="ProteomicsDB" id="55551">
<molecule id="P42771-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55552">
<molecule id="P42771-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55553">
<molecule id="P42771-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="55554">
<molecule id="P42771-4"/>
</dbReference>
<dbReference type="TopDownProteomics" id="P42771-1">
<molecule id="P42771-1"/>
</dbReference>
<dbReference type="ABCD" id="P42771">
<property type="antibodies" value="8 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="3608">
<property type="antibodies" value="1402 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="1029"/>
<dbReference type="Ensembl" id="ENST00000304494">
<molecule id="P42771-1"/>
<property type="protein sequence ID" value="ENSP00000307101"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000380151">
<molecule id="P42771-3"/>
<property type="protein sequence ID" value="ENSP00000369496"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000494262">
<molecule id="P42771-2"/>
<property type="protein sequence ID" value="ENSP00000464952"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000498124">
<molecule id="P42771-4"/>
<property type="protein sequence ID" value="ENSP00000418915"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000498628">
<molecule id="P42771-2"/>
<property type="protein sequence ID" value="ENSP00000467857"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000578845">
<molecule id="P42771-2"/>
<property type="protein sequence ID" value="ENSP00000467390"/>
<property type="gene ID" value="ENSG00000147889"/>
</dbReference>
<dbReference type="GeneID" id="1029"/>
<dbReference type="KEGG" id="hsa:1029"/>
<dbReference type="UCSC" id="uc003zpj.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc003zpk.4">
<molecule id="P42771-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="1029"/>
<dbReference type="DisGeNET" id="1029"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000147889.16"/>
<dbReference type="GeneCards" id="CDKN2A"/>
<dbReference type="HGNC" id="HGNC:1787">
<property type="gene designation" value="CDKN2A"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000147889">
<property type="expression patterns" value="Tissue enhanced (blood, pituitary gland)"/>
</dbReference>
<dbReference type="MalaCards" id="CDKN2A"/>
<dbReference type="MIM" id="155601">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="155755">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="600160">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="606719">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P42771"/>
<dbReference type="OpenTargets" id="ENSG00000147889"/>
<dbReference type="Orphanet" id="404560">
<property type="disease" value="Familial atypical multiple mole melanoma syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="618">
<property type="disease" value="Familial melanoma"/>
</dbReference>
<dbReference type="Orphanet" id="1333">
<property type="disease" value="Familial pancreatic carcinoma"/>
</dbReference>
<dbReference type="Orphanet" id="524">
<property type="disease" value="Li-Fraumeni syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="252206">
<property type="disease" value="Melanoma and neural system tumor syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="99860">
<property type="disease" value="Precursor B-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="Orphanet" id="99861">
<property type="disease" value="Precursor T-cell acute lymphoblastic leukemia"/>
</dbReference>
<dbReference type="PharmGKB" id="PA106"/>
<dbReference type="eggNOG" id="KOG0504">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000163078"/>
<dbReference type="HOGENOM" id="CLU_2229116_0_0_1"/>
<dbReference type="InParanoid" id="P42771"/>
<dbReference type="KO" id="K06621"/>
<dbReference type="OMA" id="RDEDKGM"/>
<dbReference type="OrthoDB" id="1435166at2759"/>
<dbReference type="TreeFam" id="TF352389"/>
<dbReference type="PathwayCommons" id="P42771"/>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559582">
<property type="pathway name" value="Senescence-Associated Secretory Phenotype (SASP)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559585">
<property type="pathway name" value="Oncogene Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69231">
<property type="pathway name" value="Cyclin D associated events in G1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8853884">
<property type="pathway name" value="Transcriptional Regulation by VENTX"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9630791">
<property type="pathway name" value="Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9630794">
<property type="pathway name" value="Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9632697">
<property type="pathway name" value="Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9632700">
<property type="pathway name" value="Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6"/>
</dbReference>
<dbReference type="SIGNOR" id="P42771"/>
<dbReference type="BioGRID-ORCS" id="1029">
<property type="hits" value="10 hits in 883 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CDKN2A">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P42771"/>
<dbReference type="GeneWiki" id="P16_(gene)"/>
<dbReference type="GenomeRNAi" id="1029"/>
<dbReference type="Pharos" id="P42771">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="P42771">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000147889">
<property type="expression patterns" value="Expressed in adenohypophysis and 208 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P42771">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P42771">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035985">
<property type="term" value="C:senescence-associated heterochromatin focus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004861">
<property type="term" value="F:cyclin-dependent protein serine/threonine kinase inhibitor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051059">
<property type="term" value="F:NF-kappaB binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019901">
<property type="term" value="F:protein kinase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090398">
<property type="term" value="P:cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030308">
<property type="term" value="P:negative regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001953">
<property type="term" value="P:negative regulation of cell-matrix adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045736">
<property type="term" value="P:negative regulation of cyclin-dependent protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0032088">
<property type="term" value="P:negative regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042326">
<property type="term" value="P:negative regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000774">
<property type="term" value="P:positive regulation of cellular senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000111">
<property type="term" value="P:positive regulation of macrophage apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034393">
<property type="term" value="P:positive regulation of smooth muscle cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007265">
<property type="term" value="P:Ras protein signal transduction"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0090399">
<property type="term" value="P:replicative senescence"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035986">
<property type="term" value="P:senescence-associated heterochromatin focus assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="1.25.40.20">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR020683">
<property type="entry name" value="Ankyrin_rpt-contain_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR036770">
<property type="entry name" value="Ankyrin_rpt-contain_sf"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF48403">
<property type="entry name" value="SSF48403"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50297">
<property type="entry name" value="ANK_REP_REGION"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0040">ANK repeat</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0435">Li-Fraumeni syndrome</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0043">Tumor suppressor</keyword>
<feature type="chain" description="Cyclin-dependent kinase inhibitor 2A" id="PRO_0000144177">
<location>
<begin position="1"/>
<end position="156"/>
</location>
</feature>
<feature type="repeat" description="ANK 1">
<location>
<begin position="11"/>
<end position="40"/>
</location>
</feature>
<feature type="repeat" description="ANK 2">
<location>
<begin position="44"/>
<end position="72"/>
</location>
</feature>
<feature type="repeat" description="ANK 3">
<location>
<begin position="77"/>
<end position="106"/>
</location>
</feature>
<feature type="repeat" description="ANK 4">
<location>
<begin position="110"/>
<end position="139"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="5 6">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="7"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="140"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="152"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_015864" evidence="31">
<location>
<begin position="1"/>
<end position="51"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_015865" evidence="29">
<original>MMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVD</original>
<variation>GRGSAAGAGDGGRLWRTKFAGELESGSASILRKKGRLPGEFSEGVCNHRPPPGDALGAWEAKEEE</variation>
<location>
<begin position="52"/>
<end position="116"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_015866" evidence="29">
<location>
<begin position="117"/>
<end position="156"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_043577" evidence="30">
<original>DIPD</original>
<variation>EMIGNHLWVCRSRHA</variation>
<location>
<begin position="153"/>
<end position="156"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001408">
<original>D</original>
<variation>E</variation>
<location>
<position position="14"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor and a familial melanoma." id="VAR_001409">
<original>L</original>
<variation>P</variation>
<location>
<position position="16"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding." id="VAR_058549">
<original>A</original>
<variation>ATA</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung tumor and melanoma; dbSNP:rs760065045." id="VAR_001410">
<original>A</original>
<variation>P</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor; dbSNP:rs760065045." id="VAR_001411">
<original>A</original>
<variation>S</variation>
<location>
<position position="20"/>
</location>
</feature>
<feature type="sequence variant" description="In a pancreas tumor and a melanoma; loss of CDK4 binding; dbSNP:rs1064794292." id="VAR_001412">
<original>G</original>
<variation>D</variation>
<location>
<position position="23"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_001413">
<original>R</original>
<variation>C</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs104894097." id="VAR_001414" evidence="27">
<original>R</original>
<variation>P</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="Found in a patient with multiple primary melanoma; partial loss of CDK4 binding; dbSNP:rs104894097." id="VAR_058550" evidence="18">
<original>R</original>
<variation>Q</variation>
<location>
<position position="24"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001415">
<original>E</original>
<variation>D</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs878853650." id="VAR_001416" evidence="24">
<original>L</original>
<variation>P</variation>
<location>
<position position="32"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001417">
<original>E</original>
<variation>D</variation>
<location>
<position position="33"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; also found in a biliary tract tumor and a patient with uveal melanoma; partial loss of CDK4 binding; dbSNP:rs746834149." id="VAR_001418" evidence="24">
<original>G</original>
<variation>A</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs746834149." id="VAR_001419" evidence="24">
<original>G</original>
<variation>E</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding; dbSNP:rs746834149." id="VAR_058551" evidence="18">
<original>G</original>
<variation>V</variation>
<location>
<position position="35"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; also found in head and neck tumor; somatic mutation." id="VAR_001420" evidence="9">
<original>P</original>
<variation>L</variation>
<location>
<position position="48"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor; dbSNP:rs199907548." id="VAR_001421">
<original>I</original>
<variation>S</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs199907548." id="VAR_001422" evidence="19 22">
<original>I</original>
<variation>T</variation>
<location>
<position position="49"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs587778189." id="VAR_001423" evidence="24">
<original>Q</original>
<variation>R</variation>
<location>
<position position="50"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs104894095." id="VAR_001424" evidence="24 26 27">
<original>M</original>
<variation>I</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="sequence variant" description="Possible polymorphism; dbSNP:rs104894109." id="VAR_001425">
<original>S</original>
<variation>I</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In pancreas carcinoma; somatic mutation; partial loss of CDK4 binding; dbSNP:rs372266620." id="VAR_001426" evidence="9">
<original>A</original>
<variation>V</variation>
<location>
<position position="57"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs104894099." id="VAR_001427" evidence="10">
<original>V</original>
<variation>G</variation>
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs769382085." id="VAR_001428">
<original>A</original>
<variation>T</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma; loss of CDK4 binding; dbSNP:rs36204594." id="VAR_053028">
<original>A</original>
<variation>V</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_001429">
<original>EL</original>
<variation>DV</variation>
<location>
<begin position="61"/>
<end position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_001430">
<original>L</original>
<variation>P</variation>
<location>
<position position="62"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001431" evidence="23">
<original>H</original>
<variation>Y</variation>
<location>
<position position="66"/>
</location>
</feature>
<feature type="sequence variant" description="In melanoma; loss of CDK4 binding." id="VAR_058552" evidence="18">
<location>
<begin position="67"/>
<end position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; partial loss of CDK4 binding; dbSNP:rs758389471." id="VAR_058553" evidence="18">
<original>G</original>
<variation>R</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; requires 2 nucleotide substitutions; dbSNP:rs876658534." id="VAR_001432">
<original>A</original>
<variation>L</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In an esophagus tumor." id="VAR_001433">
<original>A</original>
<variation>T</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1060501260." id="VAR_001434" evidence="26">
<original>A</original>
<variation>V</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="Found in some patients with melanoma; partial loss of CDK4 binding; dbSNP:rs372670098." id="VAR_058554" evidence="18">
<original>E</original>
<variation>G</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder tumor." id="VAR_001435">
<original>E</original>
<variation>K</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung tumor." id="VAR_001436">
<original>E</original>
<variation>V</variation>
<location>
<position position="69"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_001437">
<original>N</original>
<variation>K</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs559848002." id="VAR_001438" evidence="19 22">
<original>N</original>
<variation>S</variation>
<location>
<position position="71"/>
</location>
</feature>
<feature type="sequence variant" description="In an esophagus tumor." id="VAR_001439">
<original>C</original>
<variation>G</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder tumor; dbSNP:rs760640852." id="VAR_001440">
<original>D</original>
<variation>N</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001441">
<original>D</original>
<variation>V</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding; dbSNP:rs760640852." id="VAR_058555" evidence="18">
<original>D</original>
<variation>Y</variation>
<location>
<position position="74"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding." id="VAR_058556" evidence="18">
<original>T</original>
<variation>P</variation>
<location>
<position position="77"/>
</location>
</feature>
<feature type="sequence variant" description="In a head and neck tumor." id="VAR_001442">
<original>R</original>
<variation>L</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding; dbSNP:rs1057519883." id="VAR_058557" evidence="18">
<original>R</original>
<variation>P</variation>
<location>
<position position="80"/>
</location>
</feature>
<feature type="sequence variant" description="In some patients with melanoma; impairs the function; dbSNP:rs11552823." id="VAR_001443" evidence="19">
<original>P</original>
<variation>L</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding; dbSNP:rs1334828764." id="VAR_058558" evidence="18">
<original>P</original>
<variation>T</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung tumor." id="VAR_001445">
<original>H</original>
<variation>N</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34968276." id="VAR_053029">
<original>H</original>
<variation>Q</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In a pancreas tumor; also found in head and neck tumor; dbSNP:rs121913385." id="VAR_001444">
<original>H</original>
<variation>Y</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder tumor." id="VAR_001446">
<original>D</original>
<variation>E</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001447" evidence="23">
<original>D</original>
<variation>H</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In an esophagus tumor; also found in head and neck tumor; also found in a lung tumor; dbSNP:rs11552822." id="VAR_001448">
<original>D</original>
<variation>N</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; also found in a lung tumor and a prostate tumor; dbSNP:rs11552822." id="VAR_001449" evidence="10">
<original>D</original>
<variation>Y</variation>
<location>
<position position="84"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs878853646." id="VAR_001450" evidence="26">
<original>A</original>
<variation>T</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; impairs the function; dbSNP:rs878853647." id="VAR_001451" evidence="19 22">
<original>R</original>
<variation>P</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; partial loss of CDK4 binding; dbSNP:rs749714198." id="VAR_012317" evidence="10">
<original>R</original>
<variation>W</variation>
<location>
<position position="87"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001452">
<original>E</original>
<variation>D</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; somatic mutation; dbSNP:rs137854599." id="VAR_001453" evidence="9">
<original>G</original>
<variation>D</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs137854597." id="VAR_001454">
<original>G</original>
<variation>S</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001455" evidence="23">
<original>T</original>
<variation>A</variation>
<location>
<position position="93"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_023604" evidence="15">
<original>L</original>
<variation>Q</variation>
<location>
<position position="94"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001456" evidence="23">
<original>V</original>
<variation>A</variation>
<location>
<position position="95"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding." id="VAR_001457" evidence="18">
<original>L</original>
<variation>R</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_001458">
<original>H</original>
<variation>P</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_001459">
<original>H</original>
<variation>Q</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; loss of CDK4 binding; dbSNP:rs754806883." id="VAR_001460">
<original>R</original>
<variation>P</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma; dbSNP:rs754806883." id="VAR_001461" evidence="23">
<original>R</original>
<variation>Q</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34886500." id="VAR_053030">
<original>R</original>
<variation>W</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; requires 2 nucleotide substitutions." id="VAR_001462">
<original>A</original>
<variation>L</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_001463">
<original>A</original>
<variation>P</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2 and FAMMMPC; impairs the function; dbSNP:rs104894094." id="VAR_001464" evidence="10 19 22">
<original>G</original>
<variation>W</variation>
<location>
<position position="101"/>
</location>
</feature>
<feature type="sequence variant" description="Found in seminoma and medulloblastoma tissues from Li-Fraumeni syndrome patients carrying a mutation in TP53; somatic mutation; dbSNP:rs137854598." id="VAR_015818" evidence="8">
<original>A</original>
<variation>E</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35741010." id="VAR_053031">
<original>A</original>
<variation>T</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_001465">
<location>
<begin position="104"/>
<end position="105"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs1554654024." id="VAR_001466" evidence="26">
<original>R</original>
<variation>C</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs370823171." id="VAR_001467">
<original>R</original>
<variation>H</variation>
<location>
<position position="107"/>
</location>
</feature>
<feature type="sequence variant" description="In a bladder tumor." id="VAR_001469">
<original>D</original>
<variation>H</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In a head and neck tumor; dbSNP:rs121913381." id="VAR_001468">
<original>D</original>
<variation>Y</variation>
<location>
<position position="108"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2." id="VAR_035068" evidence="25">
<original>R</original>
<variation>RR</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma; dbSNP:rs121913386." id="VAR_001470" evidence="23">
<original>P</original>
<variation>L</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="Found in some patients with melanoma; loss of CDK4 binding; dbSNP:rs104894104." id="VAR_058559" evidence="18">
<original>P</original>
<variation>S</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; somatic mutation." id="VAR_001471" evidence="9">
<original>L</original>
<variation>M</variation>
<location>
<position position="117"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs1554653960." id="VAR_001472" evidence="27">
<original>A</original>
<variation>T</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor." id="VAR_001473">
<original>E</original>
<variation>Q</variation>
<location>
<position position="119"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001474" evidence="23">
<original>E</original>
<variation>A</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001475" evidence="23">
<original>E</original>
<variation>K</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; dbSNP:rs113798404." id="VAR_035069" evidence="13">
<original>G</original>
<variation>R</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In a biliary tract tumor; dbSNP:rs113798404." id="VAR_001476">
<original>G</original>
<variation>S</variation>
<location>
<position position="122"/>
</location>
</feature>
<feature type="sequence variant" description="In leukemia; dbSNP:rs6413463." id="VAR_001477">
<original>H</original>
<variation>Q</variation>
<location>
<position position="123"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34170727." id="VAR_053032">
<original>R</original>
<variation>C</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In an esophagus tumor; dbSNP:rs747621669." id="VAR_001478">
<original>R</original>
<variation>H</variation>
<location>
<position position="124"/>
</location>
</feature>
<feature type="sequence variant" description="In CMM2; impairs the function; dbSNP:rs104894098." id="VAR_001479" evidence="12 19 22">
<original>V</original>
<variation>D</variation>
<location>
<position position="126"/>
</location>
</feature>
<feature type="sequence variant" description="In squamous cell carcinoma; dbSNP:rs6413464." id="VAR_001480" evidence="20">
<original>A</original>
<variation>S</variation>
<location>
<position position="127"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001481" evidence="23">
<original>A</original>
<variation>P</variation>
<location>
<position position="132"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma; dbSNP:rs757497674." id="VAR_001482" evidence="23">
<original>A</original>
<variation>V</variation>
<location>
<position position="134"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001483" evidence="23">
<original>H</original>
<variation>Y</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="sequence variant" description="In squamous cell carcinoma; dbSNP:rs116150891." id="VAR_001484" evidence="20">
<original>R</original>
<variation>C</variation>
<location>
<position position="144"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3731249." id="VAR_001486" evidence="9 19 22 24 25 26 27">
<original>A</original>
<variation>T</variation>
<location>
<position position="148"/>
</location>
</feature>
<feature type="sequence variant" description="In non-small cell lung carcinoma." id="VAR_001487" evidence="23">
<original>G</original>
<variation>V</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="4"/>
<end position="6"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="15"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="25"/>
<end position="32"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="33"/>
<end position="35"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="43"/>
<end position="45"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="48"/>
<end position="50"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="57"/>
<end position="64"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="65"/>
<end position="67"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="75"/>
<end position="77"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="81"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="91"/>
<end position="100"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="109"/>
<end position="111"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="114"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="124"/>
<end position="130"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="133"/>
<end position="135"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="145"/>
<end position="147"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="150"/>
<end position="153"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD11437." ref="2" evidence="31">
<original>G</original>
<variation>R</variation>
<location sequence="P42771-3">
<position position="54"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAD11437." ref="2" evidence="31">
<original>A</original>
<variation>T</variation>
<location sequence="P42771-3">
<position position="112"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1A5E"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1BI7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1DC2"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A5E"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10445844"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10484981"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10651484"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10874641"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11136714"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11506491"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12019208"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12529334"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14646619"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16782892"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17658461"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19260062"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7647780"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7970734"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7972006"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7987387"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8060323"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8595405"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8653684"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8710906"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9328469"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9425228"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10445844"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17486064"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000305"/>
<evidence key="32" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:1787"/>
</source>
</evidence>
<sequence length="156" mass="16533" checksum="E59C0E6174B48255" modified="1998-07-15" version="2">MEPAAGSSMEPSADWLATAAARGRVEEVRALLEAGALPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDAAEGPSDIPD</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

